(Q35358439)

7 August 2017

1 reference

title

Vitamin D analogues and psoriasis. (English)

1 reference

7 August 2017

0 references

Berth-Jones J

1

1 reference

PubMed ID

1390159

7 August 2017

Hutchinson PE

series ordinal

2

1 reference

PubMed ID

1390159

7 August 2017

language of work or name

English

0 references

publication date

1 August 1992

1 reference

British Journal of Dermatology

7 August 2017

1 reference

7 August 2017

127

1 reference

7 August 2017

71-78

1 reference

7 August 2017

2

1 reference

Hypocalcemia-induced pustular psoriasis of von Zumbusch. New experience with an old syndrome

7 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Calcipotriol and betamethasone valerate for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

1α,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Calcipotriol (MC 903): pharmacokinetics in rats and biological activities of metabolites. A comparative study with 1,25(OH)2D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Calcipotriol and hypercalcaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Topical calcipotriol treatment in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Contact dermatitis from MC 903, a topical vitamin D3 analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

Will 1,25-dihydroxyvitamin D3, MC 903, and their analogues herald a new pharmacologic era for the treatment of psoriasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

1,25(OH)2D3 and calcipotriol (MC903) have similar effects on the induction of osteoclast-like cell formation in human bone marrow cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1992.TB08035.X

10.1111/J.1365-2133.1992.TB08035.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

1390159